Symyx Technologies

May 21, 2009
Organization Helps Biopharmaceutical Companies Move Promising Drug Candidates to Clinical Trials Faster

Symyx Technologies Inc. has launched the Symyx Contract Development and Manufacturing Organization (CDMO). The Symyx CDMO helps biopharmaceutical companies move promising drug candidates to clinical trials faster and more reliably with integrated formulation development, and preclinical and CGMP fill/finish manufacturing.

With experience in preformulation development, formulation optimization and stability, and analytical method development, the Symyx CDMO enables faster development of highly optimized and robust drug formulations, so that clinical trials test the efficacy of drug candidates, not the limitations of the formulation. In addition, the Symyx CDMO offers full-service fill/finish execution for delivering drug products manufactured under CGMP conditions while maintaining the integrity of drug substances and meeting preclinical and Phase I and II clinical trial schedules.